Calendar

Financial calendar

27 November 2025
Interim report Q3
CEO Ola Sandborgh comments on the report day »

25 February 2026
Interim report and Year-End Report 2025

28 April 2026
Interim report Q1

12 May 2026
The Annual General Meeting

27 August 2026
Interim report Q2

5 November 2026
Interim report Q3

25 February 2027
Interim report and Year-End Report 2026

Activities

Redeye Theme: Autoimmune and Inflammatory Diseases | November 19 | Livestream
Redeye Life Science Day 2025 | December 3 | Livestream

Previous activities

Investor relations